MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

E7090 succinate

CAS No. : 1879965-80-6

MCE 站：E7090 succinate

产品活性：E7090 succinate 是具有口服活性的、选择性的、有效的 FGFR1/2/3 抑制剂，其对 FGFR1/2/3/4 的 IC₅₀ 值分别为 0.71 nM、0.50 nM、1.2 nM 和120 nM。

研究领域：Protein Tyrosine Kinase/RTK

作用靶点：FGFR

In Vitro: E7090 also inhibited the growth of SNU-16, human gastric cancer cell line harboring FGFR2 amplification with an IC₅₀ value of 3 nM.
E7090 succinate inhibited SNU-16 cell proliferation with an IC₅₀ value of 5.7 nM.
E7090 inhibits proliferation of human cancer cell lines harboring various types of FGFRs gene abnormalities such as amplification, mutation, or translocation in vitro, which are confirmed by the inhibition of FGFR signaling.
E7090 succinate has interaction kinetics with FGFR1 kinases intermediate between those of the two representative inhibitors, ａnd the residence time of E7090 succinate is 19 minutes.

In Vivo: Pharmacodynamics analysis reveals that E7090 inhibits phosphorylation of FGFRs in SNU-16 xenograft tumors in a dose-dependent manner. Overall, the in vitro ａnd in vivo studies confirm that E7090 is a potent ａnd selective FGFRs inhibitor, showing promising antitumor activities with wider therapeutic windows in preclinical cancer models harboring FGFRs gene abnormalities. E7090 (6.25-50 mg/kg, orally, once daily) treatment prolongs survival in a 4T1 mouse lung metastasis model.

相关产品：SU 5402  |  Heparan Sulfate  |  PD173074  |  Formotin  |  Gandotinib  |  KW-2449  |  Ferulic acid  |  PD-166866  |  CP-547632  |  PP58  |  SUN11602  |  R1530  |  2,5-Dihydroxybenzoic acid  |  Tyrosine kinase-IN-1  |  PD-161570  |  ARQ 069  |  PD-089828  |  SM1-71  |  SU4984

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。